Skip to contentSkip to filters

We use cookies for analytics.

Grant, Call number PAR-25-352

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)

National Institutes of Health

  • United States
  • Institution applies
  • Psychiatry, Neuropharmacology and
Related content

About

This U01 supports cooperative research on drugs, neurostimulation approaches and tools to measure target engagement in mental illness or substance use disorders. The program spans discovery, preclinical development and proof-of-concept testing.

Topics

Eligibility

Covers: U01 cooperative agreement for discovery, preclinical work and proof-of-concept testing.

The lead applicant must be an eligible US organization.

simpler.grants.govgrants.nih.gov

Eligible organizations include universities, nonprofit research organizations and other categories specified in the announcement. The lead applicant must be an eligible US organization.

Source: simpler.grants.gov